Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00204633
Status:
COMPLETED
Last Update Posted:
2009-02-16
First Post:
2005-09-13
Brief Title:
Darbepoetin Alfa in Patients With Poor Prognosis Germ Cell Tumor Treated With High-Dose Chemotherapy HD-VIP
Sponsor:
University Hospital Tuebingen
Organization:
University Hospital Tuebingen
Organization Data
Organization:
University Hospital Tuebingen
Class:
OTHER
Study ID:
jth_004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Hospital Tuebingen
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None